Fig. 2From: A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemiaA Hierarchical clustering of genes expression of the AML cells in the BM for the group of empty micelle and mPO-6 at 24 h post injection. Blue and red colors represented down-regulated or up-regulated genes respectively (n = 4). B Cluster of genes that were analyzed by Kyoto Encyclopedia of Genes and Genomes (KEGG) for identification of the affected biological processes with the treatment of mPO-6. C Genes were alternated significantly in the BM related to the CD123/IL-3 axis (n = 4). D The phosphorylation of STAT5, PI3K/AKT and the expression of NF-κB in the nucleus, cytoplasm and total protein in the group of empty micelle and mPO-6. Leukemia cells were separated from the BM of the AML mice scarified 24 h after the third i.v. injection of empty micelles or mPO-6. E Histologic sections of BM in the mice stained with H&E, the yellow arrows pointed normal cells. The expression of CD123 on AML cells in the BM F and PB G was reduced by mPO-6 (n = 4). *P < 0.05, **P < 0.01Back to article page